AAAAAA
Results:
1-23
|
Results: 23
Authors:
Wiesemann, E
Klatt, J
Sonmez, D
Blasczyk, R
Heidenreich, F
Windhagen, A
Citation: E. Wiesemann et al., Glatiramer acetate (GA) induces IL-13/Il-5 secretion in naive T cells, J NEUROIMM, 119(1), 2001, pp. 137-144
Authors:
Windhagen, A
Maniak, S
Marckmann, S
Wilkening, A
Lindert, RB
Heidenreich, F
Blasczyk, R
Citation: A. Windhagen et al., Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate, J NE NE PSY, 70(3), 2001, pp. 415-416
Authors:
Elsner, HA
Kotsch, K
Blasczyk, R
Citation: Ha. Elsner et al., Identification of the novel allele HLA-DRB11137 which probably originatedfrom DRB1*11011: implications for mismatch with its ancestor allele at bone marrow transplantation, TISSUE ANTI, 58(1), 2001, pp. 47-49
Authors:
Schmitt-Egenolf, M
Windemuth, C
Hennies, HC
Albis-Camps, M
von Engelhardt, B
Wienker, T
Reis, A
Traupe, H
Blasczyk, R
Citation: M. Schmitt-egenolf et al., Comparative association analysis reveals that corneodesmosin is more closely associated with psoriasis than HLA-Cw0602-B*5701 in German families, TISSUE ANTI, 57(5), 2001, pp. 440-446
Authors:
Elsner, HA
Drabek, J
Rebmann, V
Ambruzova, Z
Grosse-Wilde, H
Blasczyk, R
Citation: Ha. Elsner et al., Non-expression of HLA-B5111N is caused by an insertion into the cytosine island at exon 4 creating a frameshift stop codon, TISSUE ANTI, 57(4), 2001, pp. 369-372
Authors:
Trojaneck, B
Niemitz, S
Micka, B
Lefterova, P
Blasczyk, R
Scheffold, C
Huhn, D
Schmidt-Wolf, IGH
Citation: B. Trojaneck et al., Establishment and characterization of colon carcinoma and renal cell carcinoma primary cultures, CANC BIO R, 15(2), 2000, pp. 169-174
Authors:
Kotsch, K
Blasczyk, R
Citation: K. Kotsch et R. Blasczyk, The noncoding regions of HLA-DRB uncover interlineage recombinations as a mechanism of HLA diversification, J IMMUNOL, 165(10), 2000, pp. 5664-5670
Authors:
Buhlmann, A
Albis-Camps, M
Holtkamp, B
Blasczyk, R
Citation: A. Buhlmann et al., Two novel DRB alleles detected by PCR-SSO and confirmed by sequencing: DRB10317 and DRB3*0210, TISSUE ANTI, 56(6), 2000, pp. 553-555
Authors:
Elsner, HA
Schmitz, G
Ballas, M
Lenhard, V
Blasczyk, R
Citation: Ha. Elsner et al., Characterization of the novel allele HLA-B4417: implications for bone marrow transplantation, TISSUE ANTI, 56(5), 2000, pp. 463-466
Authors:
Elsner, HA
Blasczyk, R
Citation: Ha. Elsner et R. Blasczyk, Increased diversity within the HLA-B07 group: Identification of the two novel alleles B*0709 and B*0710, TISSUE ANTI, 56(4), 2000, pp. 371-375
Authors:
Elsner, HA
O'Brien, BJ
Bryan, CF
Meyer, JA
Diederich, DA
Pierce, GE
Lau, M
Terasaki, PI
Blasczyk, R
Citation: Ha. Elsner et al., HLA-B4012: a new allele with unique serological features, TISSUE ANTI, 56(2), 2000, pp. 180-183
Authors:
Elsner, HA
Pastucha, LT
Rebmann, V
Grosse-Wilde, H
Blasczyk, R
Citation: Ha. Elsner et al., Identification of the novel allele HLA-A6813 in two members of a family of Syrian origin: implications for bone marrow transplantation, TISSUE ANTI, 55(3), 2000, pp. 262-265
Authors:
Binder, T
Heym, J
Horn, B
Blasczyk, R
Citation: T. Binder et al., HLA-A2416: a new allele of the HLA-A19 lineage, TISSUE ANTI, 55(2), 2000, pp. 178-181
Authors:
Elsner, HA
Blasczyk, R
Citation: Ha. Elsner et R. Blasczyk, Identification of the novel allele HLA-B0809 in a Caucasian individual: estimation of allogeneic potential between B*08 variants, TISSUE ANTI, 55(1), 2000, pp. 74-77
Authors:
Elsner, HA
Blasczyk, R
Citation: Ha. Elsner et R. Blasczyk, Identification of the novel allele HLA-B1545: assessment of alloreactivity in case of mismatch with other B*15 alleles, TISSUE ANTI, 55(1), 2000, pp. 80-82
Authors:
Elsner, HA
Wolpl, A
Goldmann, SF
Blasczyk, R
Citation: Ha. Elsner et al., Identification of the novel allele HLA-B1546 which belongs to the serological B72 typo: implications for bone marrow transplantation, TISSUE ANTI, 55(1), 2000, pp. 83-85
Authors:
Borowski, A
van Valen, F
Ulbrecht, M
Weiss, EH
Blasczyk, R
Jurgens, H
Gobel, U
Schneider, EM
Citation: A. Borowski et al., Monomorphic HLA class I-(non-A, non-B) expression on Ewing's tumor cell lines, modulation by TNF-alpha and IFN-gamma, IMMUNOBIOL, 200(1), 1999, pp. 1-20
Authors:
Zimmermann, R
Wittmann, G
Zingsem, J
Blasczyk, R
Weisbach, V
Eckstein, R
Citation: R. Zimmermann et al., Antibodies to private and public HLA class I epitopes in platelet recipients, TRANSFUSION, 39(7), 1999, pp. 772-780
Authors:
Meyer, O
Hildebrandt, M
Schulz, B
Blasczyk, R
Salama, A
Citation: O. Meyer et al., Simultaneous genotyping of human platelet antigens (HPA) 1 through 6 usingnew sequence-specific primers for HPA-5, TRANSFUSION, 39(11-12), 1999, pp. 1256-1258
Authors:
Gassner, C
Ellemunter, H
Zahn, R
Albert, ED
Blasczyk, R
Schonitzer, D
Citation: C. Gassner et al., Unusual association of the DRB4 null allele, DRB40103102N, with HLA DRB1*0402 in a sample of Austrian patients, TISSUE ANTI, 54(3), 1999, pp. 307-309
Authors:
Kotsch, K
Wehling, J
Blasczyk, R
Citation: K. Kotsch et al., Sequencing of HLA class II genes based on the conserved diversity of the noncoding regions: sequencing based typing of HLA-DRB genes, TISSUE ANTI, 53(5), 1999, pp. 486-497
Authors:
Albis-Camps, M
Blasczyk, R
Citation: M. Albis-camps et R. Blasczyk, Fluorotyping of HLA-DRB by sequence-specific priming and fluorogenic probing, TISSUE ANTI, 53(3), 1999, pp. 301-307
Authors:
Slateva, K
Camps, MA
Blasczyk, R
Citation: K. Slateva et al., Fluorotyping of HLA-A by sequence specific priming and fluorogenic probing, TISSUE ANTI, 52(5), 1998, pp. 462-472
Risultati:
1-23
|